Evidence map›Paper›PMID 42678398›Full record

Trial reportEuropean journal of trauma and emergency surgery : official publication of the European Trauma Society2026

Antegrade transcystic balloon dilatation in emergency laparoscopic cholecystectomy with MRCP validation.

Edgar Lipping, Sten Saar, Jaan Kirss, Hardi Aaspõllu, Artjom Bahhir, Olga Gapejeva, Toomas Kangur, Mariliis Rauk, Arvo Reinsoo, Anneliise Teder and 1 more

Registry-linked trialAbstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07490730 (Antegrade Transcystic Balloon Dilatation of the Papillary Sphincter During Emergency Laparoscopic Cholecystectomy for Common Bile Duct Stones), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07490730 completednot on this map

Antegrade Transcystic Balloon Dilatation of the Papillary Sphincter During Emergency Laparoscopic Cholecystectomy for Common Bile Duct Stones: A Prospective Validation Study With Postoperative MRCP Confirmation

TypeobservationalSponsorNorth Estonia Medical CentreRan2025 to 2026Enrolled100ConditionsCholelithiasis
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Edgar LippingNorth Estonia Medical Centre, Tallinn, Estonia. edgar.lipping@regionaalhaigla.ee.ORCID http://orcid.org/0000-0002-9593-5460
Sten SaarNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0000-0002-8958-5169
Jaan KirssNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0000-0001-8413-365X
Hardi AaspõlluNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0009-0002-0436-2650
Artjom BahhirNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0009-0009-3290-0648
Olga GapejevaNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0009-0008-6621-063X
Toomas KangurNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0009-0007-5161-7843
Mariliis RaukNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0009-0000-5043-9474
Arvo ReinsooNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0000-0003-2554-8964
Anneliise TederUniversity of Tartu, Tartu, Estonia.ORCID http://orcid.org/0009-0009-1969-0519
Peep TalvingNorth Estonia Medical Centre, Tallinn, Estonia.ORCID http://orcid.org/0000-0002-9741-2073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEndoscopic retrograde cholangiopancreatography (ERCP) remains the predominant treatment of common bile duct stones but single-stage laparoscopic management via antegrade transcystic balloon dilatation (ATBD) offers a compelling alternative. All prior studies validate success solely by intraoperative fluoroscopic cholangiography, with no prospective trial employing postoperative magnetic resonance cholangiopancreatography (MRCP).

methodsThis single-centre prospective study enrolled 100 consecutive patients with confirmed CBD stones requiring emergency laparoscopic cholecystectomy (LC). ATBD was attempted in all patients. Primary outcome was MRCP-confirmed CBD stone clearance. Secondary outcomes included operative time and postoperative complications.

resultsOne hundred consecutive patients were enrolled (median age 69 years; 38% male; 56% ASA III-IV). ATBD was performed in 88 patients (88%). Postoperative MRCP was performed in 86 of 88 patients (98%), with residual stones identified in 24 (28%; 95% CI 19.5-38.2%), corresponding to an MRCP-confirmed CBD clearance rate of 72% (95% CI 61.8-80.5%). The median operative time was 90 min (IQR 75-111.5). Among the 88 patients who underwent ATBD, postoperative complications occurred in 12 (14%), most commonly pancreatitis (4.5%) and deep surgical site infection (4.5%); one patient died following severe post-procedural pancreatitis with multiorgan failure. The median hospital length of stay was 6 days (IQR 4-7.5).

conclusionPostoperative MRCP identified residual stones in 28% of patients who underwent MRCP, corresponding to an MRCP-confirmed clearance rate of 72%. These findings support the routine use of postoperative MRCP in post-procedural assessment for patients undergoing transcystic laparoscopic common bile duct exploration.

trial registrationNCT07490730, https://clinicaltrials.gov (registration date 16.03.2026).

Indexed as

Cholangiopancreatography, Magnetic ResonanceCholecystectomy, LaparoscopicDilatationGallstonesAgedFemaleHumansMaleMiddle AgedOperative TimePostoperative ComplicationsProspective StudiesTreatment OutcomeBalloon dilatationCholedocholithiasisCommon bile duct stonesLaparoscopic cholecystectomyMRCP

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.